Garg Kailash C, Kumar Suresh, Madhavi Yennapu, Bahl Mala
National Institute of Science, Technology and Development Studies, New Delhi, India.
Health Info Libr J. 2009 Mar;26(1):22-31. doi: 10.1111/j.1471-1842.2008.00779.x.
This study evaluates malaria vaccine research carried out in different parts of the world during 1972-2004 using different bibliometric indicators.
Data have been downloaded from PubMed for the period 1972-2004 using the keywords (malaria* or plasmodium or falciparum) and (vaccine*) in the title and abstract fields. The study examined the pattern of growth of the output, its geographical distribution, profile of different countries in different subfields and pattern of citations using GOOGLE Scholar.
Malaria vaccine research output is gradually increasing. The USA, followed by the UK and Australia contributed the highest number of papers. Publication activity has decreased in Switzerland and Sweden, but has increased in Brazil and China. The majority of the countries have focused on the development of asexual blood stage malaria. Citations per paper and incidence of high-quality papers for the USA, the UK, Papua New Guinea and Denmark are more than the average. The majority of the prolific institutions are located in the USA, the UK, France and Australia.
The last two decades have witnessed considerable growth in research output in this field, while a successful malaria vaccine still remains elusive. Interestingly, the countries like the USA, the UK and Australia that lead in the quantity, quality and citation of this output are often not those directly affected by malaria.
本研究使用不同的文献计量指标,评估1972年至2004年期间在世界不同地区开展的疟疾疫苗研究。
利用关键词(疟疾或疟原虫或恶性疟原虫)和(疫苗)从1972年至2004年期间的PubMed中下载数据,这些关键词需出现在标题和摘要字段中。本研究使用谷歌学术考察了产出的增长模式、其地理分布、不同子领域中不同国家的概况以及被引模式。
疟疾疫苗研究产出在逐渐增加。美国贡献的论文数量最多,其次是英国和澳大利亚。瑞士和瑞典的发表活动有所减少,但巴西和中国的发表活动有所增加。大多数国家专注于无性血液期疟疾的研发。美国、英国、巴布亚新几内亚和丹麦的每篇论文被引次数和高质量论文发生率高于平均水平。大多数多产机构位于美国、英国、法国和澳大利亚。
在过去二十年中,该领域的研究产出有了显著增长,然而成功的疟疾疫苗仍然难以实现。有趣的是,在该产出的数量、质量和被引方面领先的美国、英国和澳大利亚等国家,往往并非直接受疟疾影响的国家。